awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26751331-C98F1598-3FE1-48DE-8339-546E5AE501A3
Q26751331-C98F1598-3FE1-48DE-8339-546E5AE501A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751331-C98F1598-3FE1-48DE-8339-546E5AE501A3
Recent developments in receptor tyrosine kinases targeted anticancer therapy
P2860
Q26751331-C98F1598-3FE1-48DE-8339-546E5AE501A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751331-C98F1598-3FE1-48DE-8339-546E5AE501A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2377921822dd82c652e89b3957adb23b5e3c1831
P2860
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.